scieee Open visual document viewer

Synthesis of sugar oxazolines by intramolecular Ritter-like reaction of D-fructose precursors

Jiménez Blanco, José Luis; Rubio, Enrique M.; Ortiz Mellet, Carmen; García Fernández, José Manuel

Abstract

Treatment of D-fructopyranose and D-fructofuranosc 1,2-O-acetonide derivatives with triflic acid in the presence of a variety of nitriles results in the formation of fused or spiro 2-oxazolines. The reaction implies (i) activation of the anomeric centre with simultaneous isopropylidene cleavage, (ii) nucleophilic addition of the nitrile to the corresponding oxocarbenium cation intermediate and (iii) subsequent trapping of the resulting nitrilium ion species by the remaining hydroxyl group in an intramolecular Ritter-like reaction.

Full text

LETTER2230 Syn hesis o Suga Oxazolines by In amolecula Ri e -Like Reac ion o D-F uc ose P ecu so s Syn hesis o Suga Oxazolines José L. Jiménez Blanco,a En ique M. Rubio,b Ca men O iz Melle ,*a José M. Ga cía Fe nández*b aDepa amen o de Química O gánica, Facul ad de Química, Uni e sidad de Se illa, Ap do. 553, 41071 Se illa, Spain Fax +34(954)624960; E-mail: melle @us.es bIns i u o de In es igaciones Químicas, CSIC, Amé ico Vespucio 49, Isla de la Ca uja, 41092 Se illa, Spain Fax +34(954)460565; E-mail: joga [email protected] Recei ed 20 May 2004 SYNLETT 2004, No. 12, pp 2230–2232 01.10.2004 Ad anced online publica ion: 04.08.2004 DOI: 10.1055/s-2004-830891; A ID: D12704ST © Geo g Thieme Ve lag S u ga · New Yo k Abs ac : T ea men o D- uc opy anose and D- uc o u anose 1,2-O-ace onide de i a i es wi h i lic acid in he p esence o a a- ie y o ni iles esul s in he o ma ion o used o spi o 2-oxazo- lines. The eac ion implies (i) ac i a ion o he anome ic cen e wi h simul aneous isop opylidene clea age, (ii) nucleophilic addi ion o he ni ile o he co esponding oxoca benium ca ion in e media e and (iii) subsequen apping o he esul ing ni ilium ion species by he emaining hyd oxyl g oup in an in amolecula Ri e -like eac ion. Key wo ds: ca bohyd a es, ni iles, 2-oxazolines, spi o com- pounds, Ri e eac ion 2-Oxazolines cons i u e a wide amily o i e-membe ed he e ocycles wi h impo an applica ions in he ields o o ganic syn hesis,1 ca alysis,2,3 and pha macology.4 2- Amino-2-deoxysuga 2-oxazoline de i a i es ha e been b oadly used as glycosyl dono s in he syn hesis o na u al oligosaccha ides5 and ha e also been p oposed as glycosi- dase subs a es6 and inhibi o s.7 Recen ly, in e es in he syn hesis o he isome ic glycosylamine 2-oxazoline de- i a i es (glycosyl isooxazolines) has g own because hese compounds can se e as in e media es in he s e eo- selec i e cons uc ion o he glycosyl amide bond, a key s uc u al ea u e o N-glycop o eins.8 Howe e , u he applica ions ha e been limi ed so a due o he lack o sui able p epa a i e me hods and he ela i e ins abili y o he anome ic 2-oxazoline ing. The Ri e eac ion,9 i.e., he gene a ion o a ela i ely s a- ble ca boca ion and i s in si u apping by ni iles, o gi e ansien ni ilium species ha can unde go u he in e o in amolecula nucleophilic a ack by a sui ably loca ed g oup, is an a ac i e s a egy o he p epa a ion o a a- ie y o amide p oduc s and azahe e ocycles ha has al- eady ound u ili y in ca bohyd a e chemis y.10 T ansien glycosyl isooxazoline in e media es ha e been al eady in- oked in some Ri e -like ans o ma ions.11 Ye , only in a ew cases hey ha e been isola ed and ully cha ac e - ized.12 In p e ious wo k, we ha e shown ha D- uc ose isop opylidene de i a i es can be eadily ac i a ed wi h i lic acid o gi e a ansien b-hyd oxy oxoca benium ca ion.13 In he absence o any o he nucleophile, spi odi- saccha ides (di-D- uc ose dianhyd ides) a e o med. We now epo he ex ension o his s a egy o he s e eo- selec i e p epa a ion o used and spi o glycosyl isoxazo- lines by a Ri e -like eac ion in ol ing (i) ni ile addi ion o he uc osyl ca ion and (ii) subsequen in amolecula apping o he ini ially o med ni ilium ion by he icinal ee hyd oxyl g oup (Scheme 1). Scheme 1 Syn hesis o used and spi o glycosyl isooxazolines om D- uc ose isop opylidene de i a i es by Ri e -like eac ion A wide a ie y o ni iles was ound o pa icipa e in he addi ion-cycliza ion eac ion. In he case o 1-O-benzyl- 2,3:4,5-di-O-isop opylidene-b-D- uc opy anose (1),14 he co esponding used isooxazoline wi h b-anome ic con igu a ion (6a–d) was he only eac ion p oduc (Figu e 1 and Table 1, en ies 1–4). The s e eochemical ou come is go e ned in his case by he o ien a ion o OH- 3, o ma ion o a ans- used bicyclic sys em being p e- en ed due o s e ic s ain. Con a y o ha epo ed o p e ious p epa a ions o aldose-de i ed glycosyl isoox- azolines, compounds 6a–d we e ound o be a he s able. In ac , i is known ha he s abili y o he oxazolinium ca ion inc eases wi h he numbe o elec on-dona ing ca bon subs i uen s in he ing.15 Mo eo e , oxazolinium O O O RO O RO OH O OH N RO C R' O O N RO R' O RO O O O RO OR OH O RO OH N OR OR C R' O RO O N OR R' R'CN R'CN acid p omo o Downloaded by: Uni e sidad de Se illa. Copy igh ed ma e ial. LETTER Syn hesis o Suga Oxazolines 2231 Synle 2004, No. 12, 2230–2232 © Thieme S u ga · New Yo k i la es a e s ill mo e s able, since he i la e coun e ion is a e y weak nucleophile, which is unable o a ack he oxazolinium ing.16 Ac i a ion o 1,2:4,5-di-O-isop opylidene-b-D- uc opy - anose p ecu so s (2 and 3)14 wi h i lic acid in he p es- ence o a ni ile a o ded spi o isooxazolines (7a–d and 8, espec i ely).17 Only he b-con igu ed compounds, ha - ing he py anose ing in he 1C4 con o ma ion, we e de- ec ed, i espec i e o he pa icipa ing (benzoyl) o non- pa icipa ing cha ac e (benzyl) o he hyd oxyl p o ec ing g oup a O-3 (Table 1, en ies 5–9). I is no ewo hy ha his si ua ion implies he axial o ien a ion o he N-subs i - uen a he anome ic posi ion, a gene ally un a o able a - angemen o N-glycosidic de i a i es due o he e e se anome ic e ec .18 In ac , he p e e ence o he axial o i- en a ion has p e iously been obse ed in he case o glycosylace oni ilium ions, which ha e been apped as he co esponding imides by eac ion wi h ca boxylic acids.19 Ou esul s indica e ha his scena io is p obably gene al o glycosylni ilium sal s. Mo eo e , he de- c eased posi i e cha ge densi y a he isooxazoline ni o- gen a om, as compa ed wi h amines, in combina ion wi h he p e e ed equa o ial o ien a ion o he ca bon subs i - uen , p obably p e en s anome iza ion o he inal com- pounds, a ypical p oblem in he case o pe -O-p o ec ed glycosylamine de i a i es.20 3,4,6-T i-O-p o ec ed 1,2-O-isop opylidene-b-D- uc o- u anose de i a i es (4 and 5)21 likewise a o ded spi o isooxazolines ha ing he b-anome ic con igu a ion a he uc ose moie y upon eac ion wi h ace oni ile unde he abo e eac ion condi ions (9 and 10, espec i ely, Table 1, en ies 10 and 11). In he case o he benzoyla ed p ecu so , howe e , he cis- used bicyclic isooxazoline 11, a ising om O-3 o O-1 acyl mig a ion p io o oxazo- line ing closu e, was he majo eac ion p oduc (Table 1, en y 11), in ag eemen wi h he highe s abili y o he used isooxazoline skele on as compa ed wi h he spi o glycosyl isooxazoline amewo k. In summa y, he Ri e -based s a egy epo ed he ein is e ec i e o accessing used as well as spi o glycosyl isooxazolines om eadily ob ainable D- uc ose ace- onides. The comme cial a ailabili y o a la ge numbe o ni iles and he simplici y o he me hod should be a ac- i e no only o exploi he ich chemis y o 2-oxazolines in ca bohyd a e ans o ma ion schemes bu also o he p epa a ion o chi al 2-oxazoline lib a ies, o in e es as ligands in asymme ic ca alysis. Wo k in bo h di ec ions is cu en ly being in es iga ed in ou labo a o ies. Gene al p ocedu e: To a 0.114 M solu ion o he co esponding D- uc ose p ecu so 1–5 and he ni ile coun e pa (10 equi ) in dis- illed CH2Cl2 a –20 °C, T OH (1.5 equi ) was added unde A a - mosphe e. The eac ion mix u e was allowed o wa m up o . . and s i ed o he ime indica ed in Table 1. Then E 3N was added, he sol en s we e e apo a ed unde educed p essu e and he p oduc s we e pu i ied by column ch oma og aphy using mix u es o E OAc–pe oleum e he as eluen . All p oduc s ga e sa is ac o y MS and mic oanalysis da a in ag eemen wi h he p oposed s uc- u es. The isola ed yields a e indica ed in Table 1. Selec ed da a22 o 6a: R = 0.22 (1:2 E OAc–pe oleum e he ); [a]D –90 (c 0.8, CH2Cl2). 1H NMR (500 MHz, CDCl3): d = 7.22 (m, 5 H, Ph), 4.62 (d, 1 H, CH2Ph), 4.60 (dd, 1 H, H-4), 4.56 (d, 1 H, H-3), 4.55 (d, 1 H, CH2Ph), 4.13 (dd, 1 H, H-5), 3.73 (d, 1 H, H-1a), 3.71 (d, 1 H, H-6a) 3.59 (d, 1 H, H-1b), 3.31 (dd, 1 H, H-6b), 2.04 (s, 3 H, NMe), 1.39, 1.30 (2 s, each 3 H, CMe2) ppm. 13C NMR (125.7 MHz, CDCl3): d = 168.0 (CN), 138.1, 128.3, 127.6, 127.5 (Ph), 109.1 (CMe2), 98.7 (C-2), 73.5 (CH2Ph), 73.1 (C-1), 72.8 (C-3), 70.4 (C-5), 69.8 (C-4), 60.9 (C-6), 26.0, 24.3 (2 CMe2), 13.9 (NMe) ppm. Table 1 Glycosyl Isooxazolines Fo med by Reac ion o D-F uc ose 1,2-O-Ace onides wi h Ni iles Using T i lic Acid as P omo o a En y D-F uc ose p ecu so Ni ile Reac ion ime (h) P oduc s (yield, %) 11MeCN 1 6a (80) 21E CN 1 6b (71) 31n-P CN 5 6c (75) 41PhCN 3 6d (65) 52MeCN 1 7a (50) 62E CN 0.5 7b (63) 72n-P CN 0.5 7c (83) 82PhCN 0.5 7d (65) 93MeCN 1 8 (41) 10 4MeCN 0.5 9 (48) 11 5MeCN 3 10 (15) 11 (44) a All eac ions we e ca ied ou in CH2Cl2 a –20 °C o . . using 10 equi o he ni ile and 1.5 equi o he acid p omo o . Figu e 1 S uc u es o he used and spi o glycosyl isooxazolines p epa ed in his s udy and o he co esponding D- uc ose p ecu so s OO O O O OR OO N O O OR R' O O O O O OBn O N O O O OBn R' O OR RO O O RO O OR RO O N RO O OBz BzO O N OBz 2 R = Bn 3 R = Bz 4 R = Bn 5 R = Bz 6a–d 7a–d R = Bn 8 R = Bz, R' = Me a R' = Me b R' = E c R' = n–P d R = Ph 9 R = Bn 10 R = Bz 11 1 Downloaded by: Uni e sidad de Se illa. Copy igh ed ma e ial. 2232 J. L. Jiménez Blanco LETTER Synle 2004, No. 12, 2230–2232 © Thieme S u ga · New Yo k Selec ed da a o 7a: R = 0.54 (2:1 E OAc–pe oleum e he ); [a]D –61 (c 0.7, CH2Cl2). The co esponding 1H NMR and 13C NMR da a we e in ag eemen wi h hose epo ed in he li e a u e.17 Selec ed da a22 o 8: R = 0.34 (1:1 E OAc–pe oleum e he ); [a]D –132 (c 0.9, CH2Cl2). 1H NMR (500 MHz, CDCl3): d = 8.02–7.41 (m, 5 H, Ph), 5.44 (d, 1 H, H-3), 4.50 (dd, 1 H, H-4), 4.41 (dd, 1 H, H-6a), 4.33 (dd, 1 H, H-5), 4.11 (d, 1 H, H-6b), 4.10 (d, 1 H, H-1a), 4.05 (d, 1 H, H-1b), 2.05 (s, 3 H, NMe), 1.62, 1.36 (2 s, each 3 H, CMe2) ppm. 13C NMR (125.7 MHz, CDCl3): d = 169.5 (CO), 166.0 (CN), 138.1, 129.8, 129.4, 128.4 (Ph), 109.5 (CMe2), 100.7 (C-2), 75.2 (C-4), 74.2 (C-1), 74.1 (C-5), 72.9 (C-3) 61.1 (C-6), 27.8, 26.4 (2 CMe2), 14.3 (NMe) ppm. Selec ed da a22 o 9: R = 0.25 (1:2 E OAc–pe oleum e he ); [a]D +68 (c 1.0, CH2Cl2). 1H NMR (500 MHz, CDCl3): d = 7.37–7.24 (m, 15 H, 3 Ph), 4.67 (d, 1 H, CH2Ph), 4.62 (d, 1 H, CH2Ph), 4.54 (b s, 2 H, H-1), 4.52 (d, 1 H, CH2Ph), 4.48 (d, 1 H, CH2Ph), 4.41 (d, 1 H, CH2Ph), 4.32 (d , 1 H, H-5), 4.17 (d, 1 H, CH2Ph), 4.16 (d, 1 H, H- 3), 4.02 (dd, 1 H, H-4), 3.58 (dd, 1 H, H-6a), 3.53 (dd, 1 H, H-6b), 2.06 (s, 3 H, NMe) ppm. 13C NMR (125.7 MHz, CDCl3): d = 168.5 (CN), 138.0, 137.9, 137.4, 127.6, 126.9 (Ph), 107.8 (C-2), 87.9 (C- 3), 81.8 (C-4), 80.2 (C-5), 73.3 (C-1), 72.4, 72.1, 72.0, (CH2Ph), 69.7 (C-6), 14.5 (NMe) ppm. Selec ed da a22 o 10: R = 0.53 (1:4 E OAc–pe oleum e he ); [a]D –42 (c 1.1, CH2Cl2). 1H NMR (500 MHz, CDCl3): d = 8.08–7.24 (m, 15 H, Ph), 6.03 ( , 1 H, H-4), 4.81 (d, 1 H, H-3), 4.81 (dd, 1 H, H- 6a), 4.71 (dd, 1 H, H-6b), 4.56 (m, 1 H, H-5), 4.51 (d, 1 H, H-1a), 4.33 (d, 1 H, H-1b), 1.98 (s, 3 H, NMe) ppm. 13C NMR (125.7 MHz, CDCl3): d = 169.5 (CN), 166.3, 166.0, 165.6 (CO) 133.7, 133.6, 130.1, 129.9, 128.5, 128.3 (Ph), 106.5 (C-2), 78.8 (C-5), 78.6 (C-3), 77.1 (C-4), 73.5 (C-1), 65.9 (C-6), 14.4 (NMe) ppm. Selec ed da a22 o 11: R = 0.29 (1:4 E OAc–pe oleum e he ); [a]D –28 (c 5.8, CH2Cl2). 1H NMR (500 MHz, CDCl3): d = 8.07–7.24 (m, 15 H, Ph), 5.70 (d, 1 H, H-3), 5.61 (dd, 1 H, H-4), 4.79 (dd, 1 H, H- 6a), 4.70 (ddd, 1 H, H-5), 4.65 (dd, 1 H, H-6b), 4.32 (s, 2 H, H-1), 2.09 (s, 3 H, NMe) ppm. 13C NMR (125.7 MHz, CDCl3): d = 169.2 (CN), 133.8, 133.5, 133.3, 129.9, 129.7, 129.2, 128.8, 128.3 (Ph), 108.7 (C-2), 82.3 (C-4), 79.8 (C-5), 79.1 (C-3), 71.5 (C-1), 63.8 (C- 6), 14.5 (NMe) ppm. Acknowledgmen We hank he Spanish Minis e io de Ciencia y Tecnología o inan- cial suppo (con ac s numbe BQU2003-00937 and BCM2001- 2366-CO3-03). E. M. R. hanks he CSIC o a ellowship. Re e ences (1) Fo a e iew, see: G an , T. G.; Meye , A. I. Te ahed on 1994, 50, 2297. (2) Fo e iews, see: (a) Jönsson, C.; Hallman, K.; Ande sson, H.; S emme, G.; Malkoch, M.; Malms ön, E.; Hul , A.; Mobe g, C. Bioo g. Med. Chem. Le . 2002, 12, 1857. (b) Ghosh, A. K.; Ma hi anan, P.; Cappiello, J. Te ahed on: Asymme y 1998, 9, 1. (3) Fo ecen publica ions, see: (a) Jones, G.; Richa ds, C. J. Te ahed on: Asymme y 2004, 15, 653. (b) Aï -Haddou, H.; Hoa au, O.; C amailé e, D.; Peze , F.; Da an, J.-C.; Bala oine, G. G. A. Chem.–Eu . J. 2004, 10, 699. (4) (a) Mi chel, J. P.; Pa eden, A. G. Angew. Chem., In . Ed. Engl. 1993, 32, 1. (b) Vo b üggen, H.; K olikiewicz, K. Te ahed on 1993, 49, 9353. (5) (a) Wi mann, V.; Lenna z, D. Eu . J. O g. Chem. 2002, 1363. (b) Banoub, J. Chem. Re . 1992, 92, 1167. (c) S öckl, W. P.; Weidmann, H. J. Ca bohyd . Chem. 1989, 8, 169. (6) Colon, M.; S a eski, M. M.; Da is, J. T. Te ahed on Le . 1991, 32, 4447. (7) Knapp, S.; Yang, C.; Haimowi z, T. Te ahed on Le . 2002, 43, 7101. (8) Damkaci, F.; DeShong, P. J. Am. Chem. Soc. 2003, 125, 4408. (9) Johnson, F.; Mad one o, R. Ad . He e ocycl. Chem. 1996, 6, 95. (10) (a) Yu, M.; Pagenkop , B. L. J. Am. Chem. Soc. 2003, 125, 8122. (b) Lohse, A.; Schweize , F.; Hindsgaul, O. Comb. Chem. High Th oughpu Sc eening 2002, 5, 389. (c) Schweize , F.; Lohse, A.; O e , A.; Hindsgaul, O. Synle 2001, 1434. (d) Nai , L. G.; F ase -Reid, B.; Sza denings, A. K. O g. Le . 2001, 3, 317. (e) Ra cli e, A. J.; Kon adsson, P.; F ase -Reid, B. J. Am. Chem. Soc. 1990, 112, 5665. (11) Pa ia, A. A.; Ung-Chhun, S. A.; Du and, J.-L. J. O g. Chem. 1981, 46, 3158. (12) (a) Noo , D.; an de Ma el, G. A.; Mulde , G. J.; an Boom, J. H. Synle 1992, 224. (b) Go don, D. M.; Danishe sky, S. J. J. O g. Chem. 1991, 56, 3713. (13) Rubio, E. M.; O iz Melle , C.; Ga cía Fe nández, J. M. O g. Le . 2003, 873. (14) B ady, R. F. J . Ad . Ca bohyd . Chem. 1971, 26, 197. (15) Hole ca, M. N.; Pe cec, V. Eu . J. O g. Chem. 2000, 2257. (16) Aoi, K.; Okada, M. P og. Polym. Sci. 1996, 21, 151. (17) Compound 7a had p e iously been ob ained by eac ion o 2 wi h ime hylsilyl i la e. See: Gash, C.; P ade a, M. A.; Salameh, B. A. B.; Molina, J. L.; Fuen es, J. Te ahed on: Asymme y 2001, 12, 1267. (18) T a oska, I.; Bleha, T. Ad . Ca bohyd . Chem. Biochem. 1989, 47, 45. (19) Ra cli e, A. J.; F ase -Reid, B. J. Chem. Soc., Pe kin T ans. 1 1989, 112, 147. (20) (a) Timme s, C. M.; Tu ne , J. J.; Wa d, C. M.; an de Ma el, G. A.; Kouwijze , M. L. C. E.; G oo enhuis, P. D. J.; an Boom, J. H. Chem.–Eu . J. 1997, 3, 920. (b) Beni o, J. M.; O iz Melle , C.; Sadalapu e, K.; Lindho s , T. K.; De aye, J.; Ga cía Fe nández, J. M. Ca bohyd . Res. 1999, 320, 37. (21) Beni o, J. M.; Gómez-Ga cía, M.; O iz Melle , C.; Ga cía Fe nández, J. M.; De aye, J. O g. Le . 2001, 3, 549. (22) The no a ion o a oms o NMR da a has been kep consis en wi h ha o he pa en D- uc ose p ecu so . Downloaded by: Uni e sidad de Se illa. Copy igh ed ma e ial.